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OBJECTIVE — To assess the relevance of pulse pressure as a predictor of foot ulcers in type
2 diabetic subjects.
RESEARCH DESIGN AND METHODS — A cohort study was performed on a consec-
utive series of 1,945 type 2 diabetic outpatients without a foot ulcer at baseline. Incident foot
ulcerswereidentiﬁedthroughtheregionalhospitaldischargesystem,whichcontainsICDcodes
of current diagnoses.
RESULTS — During a follow-up of mean  SD 4.2  2.2 years, 86 ulcers were observed.
After adjusting for confounders, the highest quartiles of pulse pressure had a 2.39-fold (95% CI
1.14–5.02) risk of foot ulcers. When ischemic ulcers were considered separately, the highest
pulse pressure quartile was associated with an increased age- and sex-adjusted risk (2.08 [95%
CI 1.02–4.24]), whereas no increase of risk was observed for neuropathic ulcers.
CONCLUSIONS — Elevated pulse pressure represents an independent predictor of foot
ulcers in diabetic patients; this parameter should be considered for the stratiﬁcation of risk of
ischemic or neuroischemic ulcers.
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P
ulse pressure is a recognized risk
factor for cardiovascular disease in
nondiabetic (1–4) and diabetic
(5,6) subjects. In particular, elevated
pulse pressure is associated with in-
creased risk of arteriopathy of the lower
limbs,evenafteradjustingformeanblood
pressure (7). This study aimed to assess
the relevance of pulse pressure as a pre-
dictoroffootulcersintype2diabeticsub-
jects, which has not been speciﬁcally
investigated so far.
RESEARCH DESIGN AND
METHODS— A cohort study was
performed on a consecutive series of
1,945 type 2 diabetic outpatients referred
totheDiabetesClinicoftheGeriatricUnit
of Careggi University Hospital in Flo-
rence, Italy, between 1 December 1995
and 1 December 2000. Blood pressure
was measured using a mercury sphygmo-
manometer, with a cuff of appropriate
size, considering the mean of three mea-
surements taken 5 min apart in a sitting
position. Serum cholesterol, HDL choles-
terol, and triglycerides were measured,
usinganautomatedmethod(Aeroset,Ab-
bott Laboratories), with blood samples
drawn in the morning after an overnight
fast.Neuropathywasascertainedthrough
biothesiometry (25 V at toes) (8), and
lower limb arteriopathy was screened
through the ankle-brachial index (ABI
0.8) (9). A1C was determined with
high-performance liquid chromatogra-
phy (Menarini Diagnostics, Florence,
Italy) (upper normal limit 5.8%). Comor-
bidity was assessed through the calcula-
tion of Charlson’s comorbidity score
(CCS), which includes diabetes and its
complications, cardiovascular disease,
chronic skin ulcers, renal insufﬁciency,
liverdiseases,chronicobstructivepulmo-
nary disease, malignancies, arthritis/
arthrosis, and HIV infections (10). Pulse
pressure was calculated as the difference
between systolic and diastolic blood
pressure.
Patients were observed until death,
incidence of foot ulcer, or 31 December
2005.Footulcerswereidentiﬁedthrough
the regional hospital discharge system,
which contains ICD codes of current di-
agnoses (ICD codes 707 or 440.23); ul-
cers were considered ischemic when ICD
code 440 or 250.7 was present and neu-
ropathic with codes 357 or 250.6. This
methodidentiﬁed40(77%)of52consec-
utive cases of incident ulcers referred to
our clinic during 2004.
The 
2 test, Student’s unpaired and
paired two-sided t tests, and the Mann-
Whitney U test were used for comparisons
whenever appropriate; Spearman’s method
wasusedforcorrelations.Survivalestimates
were performed using Kaplan-Meier
curves; stepwise Cox regression was used
for multivariate analysis.
RESULTS— Patients enrolled (56.7%
women) had a mean  SD age of 64.0 
12.7 years, duration of diabetes 10.7 
10.5 years, and A1C 8.1  1.9%. Of the
1,945 patients, 50.3, 47.1, and 32.3% re-
ceived treatment with metformin, insulin
secretagogues, or insulin, respectively.
The prevalence of neuropathy, arteriopa-
thy of the lower limbs, and retinopathy
was 22.2, 10.1, and 8.8%, respectively.
Systolic, diastolic, and pulse pressure was
142.4  20.1, 81.3  10.5, and 61.1 
16.4mmHg,respectively;61.2,51.6,and
31.1% of subjects were receiving antihy-
pertensive treatment, antiaggregants, or
statins, respectively.
Patients in the highest quartile (70
mmHg) of pulse pressure had a signiﬁ-
cantly (P  0.01) higher age (70.5  8.6
vs. 62.5  13.0 years), duration of diabe-
tes (14.1  11.1 vs. 10.0  10.2 years),
CCS (2.5  1.5 vs. 2.1  1.5), and prev-
alence of neuropathy (36.3 vs. 19.2%),
arteriopathy (10.9 vs. 7.0%), retinopathy
(13.0 vs. 7.9%), microalbuminuria (16.8
vs. 10.2%), and previous stroke (7.4 vs.
3.5%); they also had higher systolic
(168  15 vs. 136  16 mmHg) but not
diastolic (82  11 vs. 81  10 mmHg)
blood pressure. No differences between
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quartile and the rest of the sample were
observed for A1C, lipid proﬁle, and BMI
(data not shown). An inverse correlation
wasobservedbetweenpulsepressureand
ABI (r  0.27; P  0.01).
Duringameanfollow-upof4.22.2
years, 86 ulcers were observed, with a
yearly incidence rate of 1.1%. Of the in-
cident ulcers, 38 were neuropathic, 15
ischemic, 20 neuroischemic, and 13 of
other origin. Age was a relevant predictor
of incident ulcers (1.05 [95% CI 1.03–
1.07]; P  0.001). After adjusting for sex
and age, other predictors included dura-
tion of diabetes (1.03 [1.01–1.05]; P 
0.001), A1C (1.20 [1.10–1.32]; P 
0.001), neuropathy (3.93 [2.55–6.05];
P  0.001), arteriopathy of the lower
limbs(4.32[2.79–7.38];P0.001),ret-
inopathy (1.97 [1.13–3.43]; P  0.017),
and previous foot ulcer (31.53 [20.17–
49.29]; P  0.001) but not cholesterol,
microalbuminuria, or renal failure (data
not shown).
Elevated pulse pressure was associ-
ated with a signiﬁcantly increased risk of
footulcers(Fig.1).Afteradjustingforage,
sex, duration of diabetes, systolic blood
pressure,andCCS,patientsinthehighest
quartilesofpulsepressurehada2.39-fold
(95% CI 1.14–5.02) risk of foot ulcers in
comparison with the rest of the sample
(P  0.022). When ischemic or neurois-
chemic ulcers were considered sepa-
rately, the highest pulse pressure quartile
was associated with a signiﬁcantly in-
creased age- and sex-adjusted risk (2.08
[1.02–4.24]; P  0.043), whereas no in-
crease of risk was observed for neuro-
pathic ulcers (1.33 [0.67–2.65]; P 
0.42).
CONCLUSIONS— Thepresentstudy
showsfortheﬁrsttimethatpulsepressure
is a relevant independent predictor of in-
cident ischemic or neuroischemic foot ul-
cers in type 2 diabetic patients. The
reduction of arterial compliance, which is
revealed by the increased pulse pressure,
facilitates atherosclerotic lesions in differ-
ent districts, including the lower limbs
(7). Impairment of insulin sensitivity,
which has been reported to be associated
with elevated pulse pressure (11), could
contribute to micro- and macrovascular
lesions responsible for foot ulcers. Fur-
thermore, elevated pulse pressure is asso-
ciated with lower ABI.
The association of elevated pulse
pressure with foot ulcers is relevant for
identiﬁcation of patients at higher risk
and their subsequent referral to more ac-
curate programs for screening of arteri-
opathy of the lower limbs and to speciﬁc
educationalinterventions.Theriskoffoot
ulcers is more than doubled in patients in
the highest quartile of pulse pressure; the
increase of risk is comparable to that at-
tributable with known neuropathy or ar-
teriopathy of the lower limbs.
Some limitations should be recog-
nized.Register-basedascertainmentofin-
cident ulcers inevitably implies that
minor lesions not requiring treatment in
hospital-based clinics are missed, which
leads to an underestimation, by at least
20%, of the actual incidence of this con-
dition. The register-based identiﬁcation
ofulcers,withnodirectobservation,does
not allow any characterization of cases.
Furthermore,pulsepressurewasassessed
only through ofﬁce measurement, which,
although similarly predictive of cardio-
vascular events, is less accurate than re-
sults of ambulatory monitoring (6).
In conclusion, elevated pulse pres-
sure represents an independent predictor
offootulcersindiabeticpatients.Thispa-
rameter should be considered for the
stratiﬁcation of risk of ischemic or neu-
roischemic ulcers.
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